Biology & Medicine News and Discussions

[firestar464]

Online medical misinformation is scarce, but older adults see most of it

https://medicalxpress.com/news/2026-02- ... older.html

[firestar464]

Snakes keep evolving into cannibals — here's what scientists think is going on

https://www.livescience.com/animals/sna ... s-going-on

[weatheriscool]

[wjfox]

First benchtop $100 genome system

25th February 2026

The long-promised $100 genome may finally be entering mainstream commercial territory. California-based Element Biosciences has launched what it describes as the first benchtop sequencing platform explicitly designed to deliver whole human genomes at that price – a step beyond earlier room-scale demonstrations by rival firms.

In 2003, scientists involved in the Human Genome Project completed the first full human genome sequence. The effort had taken 13 years of global collaboration and required $2.7 billion in funding. It provided the first complete reference map of human DNA and laid the foundation for modern genomics. What followed ranks among the steepest technological cost declines in modern history.

Between 2007 and 2012, the price of sequencing a human genome plunged at a rate that far outpaced Moore's Law – declining by several orders of magnitude to just a few thousand dollars – as companies improved sequencing chemistry, increased parallelisation and refined high-throughput platforms.

By the mid-2010s, however, the downward curve began to flatten. Providers typically charged between $600–$1,000 for high-quality whole-genome sequencing at 30× coverage, meaning each part of the genome was read about thirty times to ensure accuracy.

In recent years, the decline has resumed. At least two companies have demonstrated that laboratories can approach $100-level genome economics, but only under very high-throughput research conditions using bulky, room-scale machines.

This month, California-based Element Biosciences, founded in 2017, has introduced VITARI, describing it as "the first ever high-throughput benchtop sequencing system capable of delivering a high-quality, whole human genome at $100." The compact platform now brings large-scale sequencing capacity directly into individual laboratories rather than concentrating it in vast centralised facilities.

https://www.futuretimeline.net/blog/202 ... meline.htm

[Yuli Ban]

^ I vaguely remember this being a prediction on the timeline 15 years ago
It was probably always on there, I just have nostalgia for the predictions from 2010-2011 the most

[wjfox]

[firestar464]

Cell death in photoreceptor cells is reversible, study finds

https://phys.org/news/2026-03-cell-deat ... sible.html

[firestar464]

Protein sequencing advance offers new insights into life's foundations

https://phys.org/news/2026-03-protein-s ... -life.html

[weatheriscool]

[weatheriscool]

[weatheriscool]

GLP-1 drugs shown to fight arthritis independent of weight loss
By Michael Franco
April 09, 2026 11:35 am

A new study has shown that the popular GLP-1 weight loss drug semaglutide has the power to halt, and to some extent restore, cartilage in people suffering from osteoarthritis (OA). The finding hints at a possible use of the drug beyond weight loss.

In 2017, America's Food and Drug Administration approved the drug semaglutide for treating diabetes. In 2021 the FDA also approved it as a weight loss aid. Since then, some studies have hinted that the drug – sold popularly as Ozempic, Wegovy, and Rybelsus – might have effectiveness treating a variety of other conditions.

For example, the FLOW trial in 2024 showed that the drug reduced the risk of kidney failure and death from cardiovascular causes in patients with type 2 diabetes and chronic kidney disease. Another 2024 study showed that the drug positively impacted motor activity in Parkinson's patients and helped ward off brain shrinkage and cognitive decline in Alzheimer's patients, although a follow-up study has brought these results into question.

https://refractor.io/medical/ozempic-se ... arthritis/

[weatheriscool]

HHS to Employ Biometrics in Health Records Portal for Seniors

Source: Bloomberg Law

The Trump administration announced it will roll out an online health portal that will allow seniors to access their health records through facial recognition software.

The Centers for Medicare & Medicaid Services will partner with biometric security platforms Clear and ID.me to verify patients’ identities. Once logged in, seniors can then instantly share medical records with health-care providers, eliminating the need for clipboards and manual data entry, the agency said.

Trump administartion officials say they hope to launch the full initiative around July 4.

-snip-

Read more: https://news.bloomberglaw.com/health-la ... r-seniors/

[weatheriscool]

[weatheriscool]

[weatheriscool]

[weatheriscool]

[weatheriscool]

[firestar464]

Neutrophils manufacture schizophrenia-linked protein, according to new research

https://medicalxpress.com/news/2026-05- ... otein.html

[weatheriscool]

[firestar464]

More on that by ScienceAlert:

https://www.sciencealert.com/nightly-sl ... al-success